ImmunityBio, Inc.
IBRX
$2.13
$0.010.47%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 97.76% | -29.51% | -63.88% | -43.78% | -31.31% |
| Total Receivables | 587.54% | 983.98% | 716.71% | -16.26% | 110.92% |
| Inventory | 242.34% | 266.65% | -- | -- | -- |
| Prepaid Expenses | 25.02% | 39.89% | 20.87% | 19.68% | 50.38% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 14.35% | 0.04% | -31.87% | -32.03% | -16.63% |
| Total Current Assets | 101.96% | -14.29% | -44.23% | -37.23% | -24.15% |
|
|
|||||
| Total Current Assets | 101.96% | -14.29% | -44.23% | -37.23% | -24.15% |
| Net Property, Plant & Equipment | -6.40% | -4.42% | -6.55% | -6.69% | -7.27% |
| Long-term Investments | 0.00% | -- | -- | -- | -- |
| Goodwill | 0.00% | -- | -- | -- | -- |
| Total Other Intangibles | -12.87% | -12.40% | -12.30% | -12.11% | -15.69% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.92% | 6.15% | 18.37% | 23.26% | 5.35% |
| Total Assets | 42.36% | -9.51% | -24.19% | -24.09% | -15.69% |
|
|
|||||
| Total Accounts Payable | -41.95% | -63.48% | -2.65% | -26.86% | -49.82% |
| Total Accrued Expenses | -0.95% | 0.04% | -16.60% | -4.11% | -32.29% |
| Short-term Debt | 20.34% | -- | -- | -15.39% | -7.49% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.73% | 18.66% | 21.80% | 40.66% | 58.15% |
| Total Finance Division Other Current Liabilities | -2.32% | 15.20% | 6.75% | -42.39% | -58.36% |
| Total Other Current Liabilities | -2.32% | 15.20% | 6.75% | -42.39% | -58.36% |
| Total Current Liabilities | -6.28% | -18.46% | -8.47% | -5.73% | -32.51% |
|
|
|||||
| Total Current Liabilities | -6.28% | -18.46% | -8.47% | -5.73% | -32.51% |
| Long-Term Debt | -16.02% | -16.43% | -8.05% | -10.83% | 44.42% |
| Short-term Debt | 20.34% | -- | -- | -15.39% | -7.49% |
| Capital Leases | -6.50% | -0.92% | -13.36% | -12.82% | -6.49% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 250.31% | -1.01% | -79.94% | -77.44% | -4.02% |
| Total Liabilities | -5.98% | -14.87% | -18.08% | -20.11% | 31.51% |
|
|
|||||
| Common Stock & APIC | 21.96% | 19.04% | 20.37% | 21.49% | 11.01% |
| Retained Earnings | -10.51% | -11.36% | -13.21% | -13.96% | -21.54% |
| Treasury Stock & Other | 4,751.46% | 157,200.00% | 285,185.71% | 11,880.00% | -86.99% |
| Total Common Equity | 29.64% | 18.28% | 14.53% | 16.68% | -80.99% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 29.64% | 18.28% | 14.53% | 16.68% | -80.99% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -7.81% | -7.83% | -7.77% | -7.71% | -8.02% |
| Total Equity | 29.66% | 18.29% | 14.54% | 16.69% | -81.22% |
|
|
|||||